cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
cbdMD Inc YCBD
$0.39
▲ +1.29%
(+$0.00)
⚡ High Volume
🎈 Low Float
🎢 High Beta
Open
$0.39
Prev Close
$0.38
Day Range
$0.38 – $0.40
52W Range
$0.33 – $2.56
Market Cap
$4.29M
Beta
2.43
EPS (TTM)
$-0.29
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2017-11-17 |
| Shares Out. | 11,210,000 |
| Website | cbdmd.com/ ↗ |
| Phone | 17044453060 |
| Employees | 42 |
| Revenue | $5.6M |
| Gross Profit | $3.0M |
| Net Income | -$1.1M |
| Free Cash Flow | -$2.4M |
| Total Assets | $13.1M |
| Total Liabilities | $4.9M |
| Equity | $8.2M |
About cbdMD Inc
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
cbdMD Inc is a publicly traded company under the ticker symbol YCBD on the NYSE MKT LLC, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-11-01)